UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of Tumor-infiltrating Lymphocytes in Breast Cancer after Neoadjuvant Paclitaxel Chemotherapy

Clinical cancer research, 2001-10, Vol.7 (10), p.3025-3030

2001

Volltextzugriff (PDF)

A Phase I-II Study of Adjuvant Concurrent Carboplatin and Accelerated Radiation Therapy for Triple Negative Breast Cancer: Updated Results

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E37-E38

2015

Volltextzugriff (PDF)

A Phase 1-2 Study of Adjuvant Concurrent Carboplatin and Accelerated Radiation Therapy for Triple-Negative Breast Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S170-S171

2014

Volltextzugriff (PDF)

Novel Combination of Toll-Like Receptor (TLR)-7 Agonist Imiquimod and Local Radiation Therapy in the Treatment of Metastatic Breast Cancer Involving the Skin or Chest Wall

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S111-S111

2013

Volltextzugriff (PDF)

Minimal Acute Toxicity Associated With Concurrent Adjuvant Carboplatin and Accelerated Radiation Therapy for Triple Negative Breast Cancer

International journal of radiation oncology, biology, physics, 2012-11, Vol.84 (3), p.S251-S251

2012

Volltextzugriff (PDF)

Double-Blind Trial of a Polyvalent, Shed-Antigen, Melanoma Vaccine

Clinical cancer research, 2001-07, Vol.7 (7), p.1882

2001

Volltextzugriff (PDF)

Effectiveness and Toxicity of Re-Irradiation after Breast Conserving Surgery for Recurrent Breast Cancer: A Multi-Institutional Study

International journal of radiation oncology, biology, physics, 2022-11, Vol.114 (3), p.e17

2022

Volltextzugriff (PDF)

129P Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort

Annals of oncology, 2020-05, Vol.31, p.S59-S59

2020

Volltextzugriff (PDF)

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen

Journal of clinical oncology, 1994-03, Vol.12 (3), p.553-559

1994

Volltextzugriff (PDF)

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity

Journal of clinical oncology, 1996-07, Vol.14 (7), p.1993-1999

1996

Volltextzugriff (PDF)

0203 Evaluating the needs of women living with metastatic breast cancer: A global survey

Breast (Edinburgh), 2009, Vol.18, p.S70-S70

2009

Volltextzugriff (PDF)

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study

Clinical cancer research, 1997-08, Vol.3 (8), p.1245-1252

1997

Volltextzugriff (PDF)

Abstract P2-11-11: Phase II trial of exemestane with immunomodulatory oral cyclophosphamide in metastatic hormone receptor (HR)-positive breast cancer: Prolonged progression-free survival (PFS) in patients with distinct T regulatory cell (Treg) profile

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P2-P2-11-11

2016

Volltextzugriff (PDF)

Effect of 21-gene recurrence score results on treatment recommendations in patients age 65 and older with lymph node-positive, estrogen receptor-positive breast cancer

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e11077-e11077

2010

Volltextzugriff (PDF)

Effect of 21-Gene Recurrence Score Results on Treatment Recommendations in Patients with Lymph Node-Positive, Estrogen Receptor-Positive Breast Cancer

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.2031-2031

2009

Volltextzugriff (PDF)

Recruitment in the Internet era: An efficient strategy for a study of breast cancer risk

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.1531-1531

2011

Volltextzugriff (PDF)

Pharmacokinetics of the Cardioprotector ADR-529 (ICRF-187) in Escalating Doses Combined With Fixed-Dose Doxorubicin

JNCI : Journal of the National Cancer Institute, 1992-11, Vol.84 (22), p.1725-1730

1992

Volltextzugriff (PDF)

Abstract OT2-1-02: Novel combination of toll-like receptor (TLR)-7 agonist imiquimod and local radiotherapy in the treatment of breast cancer chest wall recurrences or skin metastases

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT2-1-02-OT2-1-02

2013

Volltextzugriff (PDF)

Paclitaxel-induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration: Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment

Clinical cancer research, 2000-12, Vol.6 (12), p.4610-4617

2000

Volltextzugriff (PDF)

Importance of Providing Tailored Resources to Patients with Metastatic Breast Cancer: Results of the Global BRIDGE Survey

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.3085-3085

2009

Volltextzugriff (PDF)

PD07-03: Phase II Trial of Adjuvant TC (Docetaxel/Cyclophosphamide) Plus Trastuzumab (HER TC) in HER2−Positive Early Stage Breast Cancer Patients

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.PD07-03-PD07-03

2011

Volltextzugriff (PDF)

Cardiac Safety Results of a Phase II Trial of Adjuvant Docetaxel/Cyclophosphamide Plus Trastuzumab (Her TC) in HER2+ Early Stage Breast Cancer Patients

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (24_Supplement), p.5082-5082

2009

Volltextzugriff (PDF)

HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients

The Journal of immunology (1950), 1998-12, Vol.161 (12), p.6970-6976

1998

Volltextzugriff (PDF)

Decrease in circulating tumor cells as an early marker of therapy effectiveness

Recent results in cancer research, 2001, Vol.158, p.204

2001

Volltextzugriff (PDF)

Preliminary toxicity results of a phase II trial of adjuvant docetaxel/cyclophosphamide plus trastuzumab in HER2+ early stage breast cancer patients

Cancer research (Chicago, Ill.), 2009-01, Vol.69 (2_Supplement), p.2111

2009

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Englisch
(76)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of Tumor-infiltrating Lymphocytes in Breast Cancer after Neoadjuvant Paclitaxel Chemotherapy

A Phase I-II Study of Adjuvant Concurrent Carboplatin and Accelerated Radiation Therapy for Triple Negative Breast Cancer: Updated Results

A Phase 1-2 Study of Adjuvant Concurrent Carboplatin and Accelerated Radiation Therapy for Triple-Negative Breast Cancer

Novel Combination of Toll-Like Receptor (TLR)-7 Agonist Imiquimod and Local Radiation Therapy in the Treatment of Metastatic Breast Cancer Involving the Skin or Chest Wall

Minimal Acute Toxicity Associated With Concurrent Adjuvant Carboplatin and Accelerated Radiation Therapy for Triple Negative Breast Cancer

Double-Blind Trial of a Polyvalent, Shed-Antigen, Melanoma Vaccine

Effectiveness and Toxicity of Re-Irradiation after Breast Conserving Surgery for Recurrent Breast Cancer: A Multi-Institutional Study

129P Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen

Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity

0203 Evaluating the needs of women living with metastatic breast cancer: A global survey

Effect of prolonged topotecan infusion on topoisomerase 1 levels: a phase I and pharmacodynamic study

Abstract P2-11-11: Phase II trial of exemestane with immunomodulatory oral cyclophosphamide in metastatic hormone receptor (HR)-positive breast cancer: Prolonged progression-free survival (PFS) in patients with distinct T regulatory cell (Treg) profile

Effect of 21-gene recurrence score results on treatment recommendations in patients age 65 and older with lymph node-positive, estrogen receptor-positive breast cancer

Effect of 21-Gene Recurrence Score Results on Treatment Recommendations in Patients with Lymph Node-Positive, Estrogen Receptor-Positive Breast Cancer

Recruitment in the Internet era: An efficient strategy for a study of breast cancer risk

Pharmacokinetics of the Cardioprotector ADR-529 (ICRF-187) in Escalating Doses Combined With Fixed-Dose Doxorubicin

Abstract OT2-1-02: Novel combination of toll-like receptor (TLR)-7 agonist imiquimod and local radiotherapy in the treatment of breast cancer chest wall recurrences or skin metastases

Paclitaxel-induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration: Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment

Importance of Providing Tailored Resources to Patients with Metastatic Breast Cancer: Results of the Global BRIDGE Survey

PD07-03: Phase II Trial of Adjuvant TC (Docetaxel/Cyclophosphamide) Plus Trastuzumab (HER TC) in HER2−Positive Early Stage Breast Cancer Patients

Cardiac Safety Results of a Phase II Trial of Adjuvant Docetaxel/Cyclophosphamide Plus Trastuzumab (Her TC) in HER2+ Early Stage Breast Cancer Patients

HLA-Independent Heterogeneity of CD8+ T Cell Responses to MAGE-3, Melan-A/MART-1, gp100, Tyrosinase, MC1R, and TRP-2 in Vaccine-Treated Melanoma Patients

Decrease in circulating tumor cells as an early marker of therapy effectiveness

Preliminary toxicity results of a phase II trial of adjuvant docetaxel/cyclophosphamide plus trastuzumab in HER2+ early stage breast cancer patients

Suchergebnisse filtern